By Maksym Misichenko · Yahoo Finance ·
What AI agents think about this news
The panel's net takeaway is that while Q2 beats confirm near-term execution, the story hinges more on political risk than fundamentals, particularly the unenacted 2027 NDAA and its Oct 1 deadline. The high forward PEs (RTX at 30x, LMT at 19x) are seen as aggressive, with limited margin for error if Q3 guidance disappoints or the NDAA stalls.
Risk: The unenacted 2027 NDAA and its Oct 1 deadline, which could stall multiyear defense procurement and undermine the backlogs of RTX and LMT if not signed.
Opportunity: Sustained Middle East conflict driving multi-year procurement, as mentioned by Grok.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
RTX and Lockheed Martin both beat Q2 earnings and revenue estimates, sending shares up 7% and 10%, respectively, and expanding their record contract backlogs.
Neither company's backlog yet reflects the resumed Iran conflict, while an unenacted 2027 NDAA could threaten multiyear defense procurement contracts if not signed by October 1.
Lockheed's backlog is nearly all defense-related with limited commodity risk, whereas RTX's backlog is 58% exposed to commercial aerospace risks like fuel prices and airline capacity.
The war trade has resumed in July, and earnings from two of the U.S.'s most prominent defense contractors are leading the tape. After weak Q1 reports and a tenuous Iran ceasefire, aerospace and defense stocks deepened their drawdowns as the market repriced the re-stock trade and institutional selling intensified. But now that the war is back on and Q2 reports from defense companies are rolling in, the repricing is being repriced. Does the defense trade have staying power this time?
What RTX and Lockheed Martin Earnings Tell Us About the Defense Trade's Path Forward
Lockheed Martin Inc. (NYSE: LMT) and RTX Inc. (NYSE: RTX) are two of the largest U.S. defense contractors, and both their stocks soared at the start of the year. But the outbreak of the Iran war in late February actually marked the top of the defense trade, and shares of both companies declined 25% and 19% peak to trough, respectively, after making all-time highs in Q1. Poor Q1 earnings from Lockheed drove the deeper decline, while higher commodity prices also weighed on RTX's commercial order book.
The Q2 reports flipped the script, with both companies beating earnings-per-share (EPS) and revenue estimates and adding to their record backlogs. And crucially, not a dollar of earnings or backlog space has factored in the resumption of hostilities in Iran.
One crucial caveat to the thesis: the 2027 National Defense Authorization Act (NDAA) has not yet been enacted following a failed cloture vote in the Senate. The debate is likely just noise and posturing between the Trump administration and Congress. Still, if the NDAA isn't signed by October 1, no multiyear contracts for defense procurement can be distributed, and these contracts are the backbone of the RTX and LMT backlogs.
RTX: Clean Earnings Beat Has Stock Primed for New Highs
The drawdown in RTX shares is officially over following its Q2 2026 results. The beat was highlighted by 14.5% year-over-year (YOY) revenue growth, which topped analysts' estimates by more than 8%. EPS of $1.89 also crushed the expected $1.66, and the backlog grew 22% YOY to a record $289 billion.
More than $43 billion worth of new orders were booked in the quarter, including $20 billion for the Raytheon division (i.e., defense). This is the company's 8th consecutive beat, which may be why investors are willing to pay 30 times forward earnings for the stock.
An 8% earnings beat is rare, even for RtX, and it gave management the confidence to raise guidance for full-year sales, EPS, and free cash flow. The company now projects total 2026 EPS of $7.10 to $7.25, a 5% increase over its previous high-end estimate.
RTX shares jumped 7% on the release, but a looming issue clouds the celebration. The backlog is a mix of commercial and defense contracts, and the Collins Aerospace and Pratt & Whitney divisions account for $170 billion of the $289 billion total. Collins and Pratt are the aerospace wings of the company, with Raytheon making the weaponry, which means more than 58% of the total backlog is exposed to commodity risk through higher fuel prices and lower airline capacity—two factors exacerbated by the Iran war.
RTX shares are just a hair below their previous all-time high following the 7% earnings pop, and the technical signals are pointing toward more short-term gains. The stock now trades comfortably above the 50-day and 200-day moving averages, which are converging into a Golden Cross. The MACD indicator has also reached positive territory above the histogram, and a bullish cross hints at more upside to come.
Lockheed Martin: Headline Numbers Mislead, But Backlog Stronger Than Ever
On first glance, Lockheed Martin blew the market away in Q2 2026, beating top and bottom line estimates with EPS of $7.94 on $1.8 billion in net income.
This represents more than 400% YOY earnings growth, but that figure is flattered by the $1.6 billion losses absorbed by Lockheed in Q2 2025, which depressed the year-ago base. Still, the stock popped 10% on the day for a reason.
First, the backlog continues to reach record levels, growing to $230 billion, up from $193 billion at the end of 2025. The Q2 haul was especially impressive as Lockheed booked $65 billion in new orders in the period. Missiles and Fire Control (MFC) remains the shining segment, with a backlog of $87 billion for THAAD interceptors, GMLRS, HIMARS, and radar systems.
Additionally, Lockheed's cash pile shows very real gains over the previous year's quarter. Operating cash flow was $3.2 billion, and quarterly free cash flow came in at $2.25 billion. Management also boosted the top end of full-year revenue guidance to $81.75 billion, up from $80 billion in the previous quarter.
LMT shares had a deeper drawdown this spring, falling from an all-time high of $676 on March 2 to $491 by the end of June. The stock declined more steeply than RTX due to its poor Q1 earnings, but it may also have more upside given its unique exposure to the war in Iran. The company's backlog is nearly all defense, meaning limited commodity risk compared to RTX.
The chart also shows a violent reversal, with the 10% pop breaking through both the 50-day and 200-day moving averages. The Relative Strength Index (RSI) has also moved above 50 into bullish territory, but the stock is still about 16% below the March all-time high. At 19 times forward earnings, LMT is cheaper than RTX, but its backlog is less diversified, and another sudden ceasefire would pressure Lockheed's Q3 guidance.
Four leading AI models discuss this article
"LMT offers better risk/reward than RTX at 19x forward with nearly 100% defense backlog that has yet to reflect resumed Iran conflict orders."
RTX and LMT's Q2 2026 beats, record $289B and $230B backlogs, and raised guidance are unambiguously positive, with zero Iran-war revenue yet booked. RTX's 14.5% revenue growth and 8% EPS beat justify the 7% pop; LMT's $65B orders and MFC strength support the 10% surge. At 19x forward for LMT vs 30x for RTX, valuation dispersion makes sense given RTX's 58% commercial-aerospace exposure. The unenacted 2027 NDAA risk by Oct 1 is real but likely posturing. Strongest near-term tailwind is sustained Middle East conflict driving multi-year procurement.
A sudden ceasefire or de-escalation (as occurred after Q1) would immediately pressure LMT guidance far more than RTX, while RTX's Pratt & Collins backlog remains hostage to jet-fuel spikes and airline capacity cuts; both stocks are still vulnerable to any renewed institutional rotation out of 'war trades' into growth.
"The defense trade is currently driven by political speculation on the NDAA and short-term volatility, masking the fundamental risks of execution delays and overextended valuations in RTX."
The market is conflating a 'restocking' cycle with a 'war' cycle. While LMT and RTX posted impressive beats, the 30x forward P/E for RTX is aggressive, pricing in perfection for its commercial aerospace segment despite persistent supply chain bottlenecks and fuel price sensitivity. LMT offers better value at 19x, but the reliance on the 2027 NDAA is a massive structural tail risk—if political gridlock persists past October 1, the 'backlog' becomes an unexecutable liability. I am skeptical of the 'war trade' narrative; defense stocks are currently oscillating based on headline-driven volatility rather than fundamental shifts in long-term procurement budgets.
If geopolitical instability creates a permanent 'high-threat' environment, the market will likely assign a higher terminal multiple to defense prime contractors, rendering current valuation concerns irrelevant.
"Strong Q2 beats are real, but the article treats the NDAA deadline and unmonetized geopolitical upside as afterthoughts when they're actually the hinge pins for whether these valuations hold."
The article conflates two separate bullish catalysts—strong Q2 execution and geopolitical tailwinds—without stress-testing the durability of either. RTX's 8-beat streak and 22% backlog growth are real, but 58% commercial aerospace exposure means fuel prices and airline demand are structural headwinds, not temporary. Lockheed's $230B backlog is impressive, but the article glosses over a critical vulnerability: the NDAA deadline (Oct 1) isn't 'noise'—if missed, multiyear contract awards freeze entirely, and both companies' guidance becomes fiction. The 'resumed Iran conflict' hasn't actually materialized into new orders yet; the backlog reflects pre-July assumptions. Valuations have already re-rated (RTX at 30x forward, LMT at 19x), leaving limited margin for error if Q3 guidance disappoints or the NDAA stalls.
If the NDAA passes (high probability) and Iran escalation sustains through year-end, both backlogs convert to revenue faster than priced in, and the 7-10% pops understate the repricing upside. The article may be too pessimistic on execution risk.
"Backlog quality and earnings visibility for RTX and LMT depend more on NDAA enactment and geopolitics than on current Q2 beats."
Q2 beats confirm near-term execution, but the story hinges more on political risk than fundamentals. The 2027 NDAA remains unenacted, and if not signed by Oct 1, multiyear defense procurement could stall—undermining the very backbone of RTX and LMT backlogs. RTX’s 58% commodity-exposed backlog (Collins and Pratt) leaves it vulnerable to fuel spikes and air-travel demand swings, even as Raytheon and RTX defense orders grow. LMT is defense-heavy, but Iran-related geopolitics could abruptly alter spending trajectories or intensify supply-chain volatility. The implied multiple on RTX (article cites ~30x forward) looks stretched if defense growth stalls; a drama-free war tailwind is unlikely to persist.
Even if NDAA passes, the defense budget could plateau; the market may have priced in a peak cycle. And if Iran tensions cool, the tailwinds could fade faster than expected.
"Even with NDAA passage, real defense budgets and commercial aero demand face material downside not yet priced."
Claude correctly flags the NDAA Oct 1 cliff yet underweights second-order budget dynamics: even if passed, FY27 topline may shrink 4-6% in real terms post-inflation and debt-ceiling fights. RTX's 58% commercial exposure doesn't just face fuel risk; a China slowdown could cut widebody deliveries 20%+, dwarfing any Iran-driven missile upside. Backlogs are real, but conversion velocity assumptions look heroic.
"Structural labor shortages in aerospace will prevent the rapid backlog conversion necessary to justify current forward P/E valuations."
Grok is right about the China widebody risk, but everyone is ignoring the labor constraint. RTX and LMT aren't just fighting budget cycles; they are fighting a structural shortage of skilled aerospace engineering talent that caps throughput regardless of backlog size. Even if the NDAA passes, these companies cannot convert orders into revenue at the pace the market expects. We are looking at a supply-side ceiling that makes current forward P/E multiples fundamentally unsustainable.
"Labor scarcity is a *velocity dampener*, not a *demand killer*—the backlog still converts, just on a longer runway than priced in."
Gemini's labor constraint angle is real, but it's being overstated as a *ceiling* rather than a *timing* issue. RTX and LMT have both raised FY26-27 guidance post-beat, implying they've already modeled headcount constraints into conversion schedules. The constraint is real—it explains *why* backlogs aren't converting faster—but it doesn't invalidate the backlog's value; it just extends the revenue tail. The risk isn't that orders won't convert; it's that they convert slower than the market's current guidance assumes, pressuring 2027-28 estimates.
"Oct 1 NDAA timing risk is a real backlog-to-revenue throttle, especially for RTX's 58% commercial exposure, and a slip could reprice risk toward growth fatigue even with persistent geopolitics."
Gemini overstated 'war-trade' valuation with a labor bottleneck risk that may cap upside. The NDAA timing cliff isn't just a headline risk—it could throttle backlog conversion and drag Q3/Q4 realism, especially for RTX with 58% commercial exposure where fuel and airline demand compound. If approvals slip, the market might re-rate defensives faster than expected, making today's multiples too optimistic even under a sustained geopolitical backdrop.
The panel's net takeaway is that while Q2 beats confirm near-term execution, the story hinges more on political risk than fundamentals, particularly the unenacted 2027 NDAA and its Oct 1 deadline. The high forward PEs (RTX at 30x, LMT at 19x) are seen as aggressive, with limited margin for error if Q3 guidance disappoints or the NDAA stalls.
Sustained Middle East conflict driving multi-year procurement, as mentioned by Grok.
The unenacted 2027 NDAA and its Oct 1 deadline, which could stall multiyear defense procurement and undermine the backlogs of RTX and LMT if not signed.